The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
The Abortion in the United States Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade. It features a continuously-updated map tracking the status of abortion bans across the United States, as well as briefs on topics such as medication abortion, insurance coverage, ballot measures, legal developments, and racial and ethnic disparities. It also offers a jumping off point to the latest national and state-specific abortion policies and statistics. Visit the Dashboard →
As HB7 is implemented later this year...it is likely that “copycat” legislation will be adopted in other states that wish to restrict access to medication abortion via telehealth within their borders.
This policy watch explains how abortion coverage works in ACA Marketplace plans, state actions to include or exclude abortion coverage in these plans, and the potential impact if Congress bans abortion coverage in all Marketplace plans.
While the Affordable Care Act’s enhanced premium tax credits expired at the end of 2025, there is no absolute drop-dead date for extending them. An extension could happen even after the deadline to sign up for coverage and be made retroactive to January 1. Open enrollment could also be extended to allow people time to change their plans or allow new people to sign up. ACA enrollees would welcome premium relief whenever it comes.
This policy watch explains the April 21, 2023 United States Supreme Court's ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA's approval of mifepristone, the medication abortion pill.
If the Supreme Court overturns Roe v Wade, the landmark decision that established the right to abortion, then individual states can regulate abortion without any federal requirement to protect abortion access. While about half of the states in the U.S. will move to either ban or highly restrict abortion access for their residents, there is growing momentum in a handful of states to not only protect abortion access for their state residents, but also to…
Many states impose a jail sentence for doctors who perform abortions past state established gestational limit. Here's the breakdown of the jail time and state established gestational limits in effect as of May 2022.
On June 9, KFF released findings from a national public opinion survey on abortion. The event highlighted key issues including awareness and attitudes of the impending Supreme Court opinion, its potential impact on abortion access, the importance of abortion policy to voting preferences in this year’s midterm elections, and knowledge of abortion and related health care.
This volume explores false claims suggesting abortions occur after birth, misleading narratives around the safety abortion pills, like mifepristone, and other tactics used to distort the safety of abortions. It also explores research on the acceptance of health misinformation and the proliferation of AI-generated fake news sites.
KFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health. The dashboard provides instant access the most up-to-date state level indicators of women’s health in the U.S. Many of the indicators also provide national and state-level information for women of different racial and ethnic groups. Dashboard topics include: Abortion availability, coverage, and use by race/ethnicity. Maternal and infant mortality, preterm…
According to an analysis of responses to KFF’s Employer Health Benefits Survey in 2023, relatively few (8%) large firms (with 200 or more workers) offering health benefits report reducing or expanding coverage for abortion since the U.S. Supreme Court overturned Roe v. Wade with the Dobbs v. Jackson ruling. Since Dobbs, 3% of these large firms reduced or eliminated coverage for abortion where it is legal. Meanwhile, 12% of large firms whose largest plan covers…
© 2026 KFF